Bristol-Myers Squibb, Makers of Plavix, Face Injury Lawsuits Plavix Patients' Lawsuit Comes on Heels of Class Action Suit Announced by

Third-Party Payors Last Week



    SAN FRANCISCO, Oct. 31 /PRNewswire/ -- The first personal injury
 lawsuit against the makers of Plavix(R), Bristol-Myers Squibb and
 Sanofi-Aventis, has been filed. Among the allegations are misleading the
 public and hiding the risks of the popular blood thinning drug, Plavix(R).
 The lawsuit, filed on behalf of an individual injured by Plavix, comes just
 days after third-party payors announced they had filed a class action
 against the companies, alleging that Plavix causes much higher risks of
 heart attack, stroke, internal bleeding and death than previously reported.
 The suit further alleges that the company knew this information and had
 been warned repeatedly by the FDA to stop its misleading advertising and
 promotional practices.
     For years, Plavix(R) has been heavily marketed to patients and doctors
 as a "super-aspirin" that would give a person greater cardiovascular
 benefits than a much less expensive, daily aspirin, while being safer on a
 person's stomach than aspirin. The result is that doctors have been
 prescribing Plavix(R) to people for whom it is not medically necessary, and
 causing people who could be protected against heart attack and stroke with
 a simple aspirin to pay approximately $4 a day for a dose of Plavix that
 may cause the very symptoms the person is trying to avoid.
     A recent study published in the New England Journal of Medicine in
 April 2006, found that "although doctors believe the combination of
 Plavix(R) and aspirin should reduce the risk of a second heart attack, the
 combination not only does not help, but it nearly doubles the risk of
 death, heart attack or stroke in people with no history of heart disease."
     "BMS and Sanofi repeatedly thwarted the law and their duty to inform
 the public about the drug they were over promoting for profit," said Nancy
 Hersh, Principle, Hersh and Hersh. "They misinformed physicians about who
 should be given Plavix(R) and about the proper applications for the drug,
 causing people to die and be seriously injured as a result."
     The lawsuit was filed by Hersh & Hersh and Miller & Associates on
 behalf of Dorothy Hall and Thomas Hall, husband and wife. Dorothy hall was
 prescribed and used Plavix from December 20, 2002 to Oct 4, 2005 for the
 purpose of preventing a heart attack or stroke. Dorothy thereafter suffered
 two separate strokes, each requiring medical attention. Had Dorothy been
 properly warned of the risks of using Plavix, she never would have used it.
     Hersh & Hersh represents the Halls in this ground-breaking suit against
 the makers of Plavix. Hersh & Hersh has a history of leading the
 plaintiff's bar in filing injury lawsuits against drug-makers, having filed
 the first Fen-Phen lawsuit and the first suit against Eli Lily for the
 drug, Zyprexa.
     For more information, please contact Charles Kelly @ Hersh & Hersh,
 415-441-5544 or Severn Williams 510-336-9566.
 
 

SOURCE Hersh & Hersh

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.